TREM1 and arthritic joint disease: To further elucidate the molecular mechanisms underlying the reduction in severity of CIA in mice treated with TREM‐1 inhibitory GF9 sequences, we next analysed the plasma cytokine levels on day 24 at the start of treatment, on day 30 at around the disease peak and on day 38 when the arthritis swelling was at the plateau region.